COVID19
06 Dec 2021
Trial Summary
What are the specific risk factors related to poor outcome in cancer patients infected with COVID-19 virus?
Acronym:
COVID19
ACTRN/NCT /ethics:
–
Scientific title:
–
Sponsor / Cooperative group:
–
Trial & Patient Characteristics
| Cancer Type | All cancers |
|---|---|
| Trial Type | - |
| Phase | - |
| Age Range | - |
| Sex | - |
| Tumour Stream | Cancer-related Subgroup |
| Cancer Stage | - |
| Anticipated Start Date | - |
| Anticipated End Date | - |
Participating Hospitals
| Hospital | Flinders Medical Centre |
|---|---|
| Clinical Trial Coordinator | Hannah Adelson |
| Hannah.adelson@sa.gov.au | |
| Phone | 08 8206 4835 |
| Principal Investigator | Dr Anna Mislang |
| Recruitment Status | Recruiting |